0000950170-24-028811.txt : 20240308
0000950170-24-028811.hdr.sgml : 20240308
20240308174040
ACCESSION NUMBER: 0000950170-24-028811
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stout Stephen
CENTRAL INDEX KEY: 0001970664
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39593
FILM NUMBER: 24735853
MAIL ADDRESS:
STREET 1: C/O SHATTUCK LABS, INC.
STREET 2: 500 W. 5TH STREET, SUITE 1200
CITY: AUSTIN
STATE: TX
ZIP: 78701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shattuck Labs, Inc.
CENTRAL INDEX KEY: 0001680367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812575858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
BUSINESS PHONE: 512-900-4690
MAIL ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
4
1
ownership.xml
4
X0508
4
2024-03-06
0001680367
Shattuck Labs, Inc.
STTK
0001970664
Stout Stephen
C/O SHATTUCK LABS, INC.
500 W. 5TH STREET, SUITE 1200
AUSTIN
TX
78701
false
true
false
false
See Remarks
true
Common Stock
2024-03-06
4
M
false
4650
3.51
A
83982
D
Common Stock
2024-03-06
4
S
false
4650
10.53
D
79332
D
Common Stock
2024-03-06
4
M
false
6459
3.57
A
85791
D
Common Stock
2024-03-06
4
S
false
6459
10.53
D
79332
D
Common Stock
2024-03-06
4
S
false
4895
10.53
D
74437
D
Stock Option (Right to Buy)
3.51
2024-03-06
4
M
false
4650
0.00
D
2032-09-08
Common Stock
4650
9300
D
Stock Option (Right to Buy)
3.57
2024-03-06
4
M
false
6459
0.00
D
2033-01-25
Common Stock
6459
17391
D
Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023.
The stock option was granted to the Reporting Person on September 8, 2022, one-third of which vested on September 8, 2023 and the remaining two-thirds of which will vest on September 8, 2024.
The stock option was granted to the Reporting Person on January 25, 2023, one-quarter of which vested on January 10, 2024 and the remaining three-quarters of which will vest in approximately equal monthly installments through January 10, 2027.
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
/s/ Stephen Stout
2024-03-08